Alzheimer Disease Blood Biomarker Concentrations Across Race and Ethnicity Groups in Middle-Aged Adults
JAMA Network Open 10.1001/jamanetworkopen.2025.45046November 21, 2025 at 11:00 AM EST
Do the concentrations of plasma biomarkers associated with Alzheimer disease differ among race and ethnicity groups in middle-aged adults?In this cohort study of 4340 adults approximately 58 years of age in the High School and Beyond study, compared with White participants, Black participants had lower amyloid-β (Aβ)42/Aβ40 ratios and lower neurofilament light chain concentrations, and Latinx participants had lower glial fibrillary acidic protein concentrations, but these differences were attenuated when statistical techniques were applied to ensure population representation. Common medical conditions, including type 2 diabetes, high cholesterol, and high body mass index, were associated with biomarker concentrations, but these associations did not differ across race and ethnicity groups.This study found that Alzheimer disease–associated biomarker concentrations were similar among race and ethnicity groups for middle-aged adults when sampling and statistical modeling techniques were used to ensure population representation.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.